1-4 of 4
Samir Tawadros
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

Katrin S. Reiners, Daniela Topolar, Alexander Henke, Venkateswara R. Simhadri, Jörg Kessler, Maike Sauer, Martina Bessler, Hinrich P. Hansen, Samir Tawadros, Marco Herling, Martin Krönke, Michael Hallek, Elke Pogge von Strandmann
Journal: Blood
Blood (2013) 121 (18): 3658–3665.
https://doi.org/10.1182/blood-2013-01-476606
Published: 2013
Includes: Supplemental data
Journal Articles

Prenylation Inhibitors as Potential Therapeutic Drugs in Hodgkin Lymphoma.

Bastian von Tresckow, MD, Peer Langendorf, Elke Pogge von Strandmann, PhD, Stefanie Sasse, MD, Samir Tawadros, Andreas Engert, MD, Hinrich P. Hansen, PhD
Journal: Blood
Blood (2006) 108 (11): 2513.
https://doi.org/10.1182/blood.V108.11.2513.2513
Published: 2006
Journal Articles

The Human Anti-CD30 Antibody 5F11 Activates NF-kB and Sensitizes Lymphoma Cells to Bortezomib Induced Apoptosis.

Elke Pogge, PhD, Boris Boell, MS, Samir Tawadros, MS, Katrin Reiners, PhD, Peter Borchmann, MD, Hinrich Hansen, PhD, Robert Graziano, PhD, Michael Yellin, MD, Andreas Engert, MD
Journal: Blood
Blood (2004) 104 (11): 3295.
https://doi.org/10.1182/blood.V104.11.3295.3295
Published: 2004
Journal Articles

Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice

Stefan Barth, Michael Huhn, Bärbel Matthey, Samir Tawadros, Roland Schnell, Timo Schinköthe, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2000) 95 (12): 3909–3914.
https://doi.org/10.1182/blood.V95.12.3909
Published: 2000